Page 175 - Pagetit
P. 175

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE



                   Charness ME (1999) Intracranial voyeurism: revealing the mammillary bodies in
                   alcoholism. Alcoholism: Clinical and Experimental Research, 23:1941–1944.
                   Checkoway H (1998) A genetic polymorphism of MAO-B modifies the association
                   of cigarette smoking and Parkinson’s disease. Neurology, 50:1458–1461.
                   Chen CC et al. (1999) Interaction between the functional polymorphisms of the
                   alcohol-metabolism genes in protection against alcoholism. American Journal
                   of Human Genetics, 65:795–807.
                   Cheng LS, Swan GE, Carmelli D (2000) A genetic analysis of smoking behavior in
                   family members of older adult males. Addiction, 95:427–435.
                   Comings DE, Blum K (2000) Reward deficiency syndrome: genetic aspects of
                   behavioral disorders. Progress in Brain Research, 126:325–341.
                   Comings DE et al. (1996) The dopamine D2 receptor (DRD2) gene: a genetic risk
                   factor in smoking. Pharmacogenetics, 6:73–79.

                   Comings DE et al. (1997) Studies of the potential role of the dopamine D1 receptor
                   gene in addictive behaviors. Molecular Psychiatry, 2:44–56.
                   Comings DE et al. (2001) Cholecystokinin (CCK) gene as a possible risk factor for
                   smoking: a replication in two independent samples. Molecular Genetics and
                   Metabolism, 73:349–353.
                   Connor JP et al. (2002) D2 dopamine receptor (DRD2) polymorphism is associated
                   with severity of alcohol dependence. European Psychiatry, 17:17–23.
                   Cooper B (2001) Nature, nurture and mental disorder: old concepts in the new
                   millennium. British Journal of Psychiatry, 178(Suppl. 40):S91–S101.
                   Crabbe JC (2002) Genetic contributions to addiction. Annual Review of Psychology,
                   53:435–462.
                   Cravchik A, Gejman PV (1999) Functional analysis of the human D5 dopamine
                   receptor missense and nonsense variants: differences in dopamine binding
                   affinities. Pharmacogenetics, 9:199–206.
                   Crawley JN, Corwin RL (1994) Biological actions of cholecystokinin. Peptides,
                   15:731–755.
                   Crawley JN et al. (1997) Behavioral phenotypes of inbred mouse strains:
                   implications and recommendations for molecular studies. Psychopharmacology
                   (Berlin), 132:107–124.

                   Daeppen JB et al. (2000) Clinical correlates of cigarette smoking and nicotine
                   dependence in alcohol-dependent men and women: the Collaborative Study
                   Group on the Genetics of Alcoholism. Alcohol and Alcoholism, 35:171–175.
                   David SP et al. (2002) No association between functional catechol O-methyl
                   transferase 1947A>G polymorphism and smoking initiation, persistent smoking
                   or smoking cessation. Pharmacogenetics, 12:265–268.

                   Duggirala R, Almasy L, Blangero J (1999) Smoking behavior is under the influence
                   of a major quantitative trait locus on human chromosome 5q.  Genetic
                   Epidemiology, 17 Suppl 1:S139–S144.
                   Edwards KL, Austin MA, Jarvik GP (1995) Evidence for genetic influences on
                   smoking in adult women twins. Clinical Genetics, 47:236–244.


                                                  154




          Chapter_5                154                             19.1.2004, 11:46
   170   171   172   173   174   175   176   177   178   179   180